+7.18%
Today
Loading 1D prices…
Company profile
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Malvern, PA, United States
Employees
218
Fiscal year end
1231
CIK
1561921
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PAVMPAVmed Inc. Common Stock | $41.1M | $71K | -5315.49% | -$5.63 | -2.11% | Buy |
| XTNTXtant Medical Holdings Inc. Common Stock | $48.5M | $133.9M | +0.00% | $0.03 | +2.94% | Buy |
| NEPHNephros Inc. Common Stock | $48.5M | $18.8M | +6.35% | $0.11 | -1.11% | Hold |
| NSPRInspireMD Inc. Common Stock | $37M | $9M | -543.36% | -$0.76 | +1.27% | Buy |
| MDAISpectral AI Inc. Class A Common Stock | $51.5M | $19.7M | -38.53% | -$0.29 | +3.14% | Buy |